List of Tables
Table 1. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Plasma Protein Therapeutics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Plasma Protein Therapeutics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Plasma Protein Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Plasma Protein Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Plasma Protein Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Plasma Protein Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Protein Therapeutics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 18. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)
Table 20. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 27. North America Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 28. North America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Recombinant Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Type (2019-2024)
Table 51. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Type (2025-2030)
Table 52. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 59. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2025-2030)
Table 60. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Application (2019-2024)
Table 61. Global Recombinant Plasma Protein Therapeutics Sales (K Units) by Application (2025-2030)
Table 62. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Plasma Protein Therapeutics Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Plasma Protein Therapeutics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2024)
Table 69. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2025-2030)
Table 70. CSL Limited Corporation Information
Table 71. CSL Limited Description and Business Overview
Table 72. CSL Limited Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. CSL Limited Recombinant Plasma Protein Therapeutics Product
Table 74. CSL Limited Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Takeda Recombinant Plasma Protein Therapeutics Product
Table 79. Takeda Recent Developments/Updates
Table 80. Octapharma Corporation Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Octapharma Recombinant Plasma Protein Therapeutics Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Novo Nordisk A/S Corporation Information
Table 86. Novo Nordisk A/S Description and Business Overview
Table 87. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product
Table 89. Novo Nordisk A/S Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Recombinant Plasma Protein Therapeutics Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Bioverativ Therapeutics Corporation Information
Table 96. Bioverativ Therapeutics Description and Business Overview
Table 97. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product
Table 99. Bioverativ Therapeutics Recent Developments/Updates
Table 100. Aptevo Therapeutics Corporation Information
Table 101. Aptevo Therapeutics Description and Business Overview
Table 102. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product
Table 104. Aptevo Therapeutics Recent Developments/Updates
Table 105. Pharming Group Corporation Information
Table 106. Pharming Group Description and Business Overview
Table 107. Pharming Group Recombinant Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Pharming Group Recombinant Plasma Protein Therapeutics Product
Table 109. Pharming Group Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Recombinant Plasma Protein Therapeutics Distributors List
Table 113. Recombinant Plasma Protein Therapeutics Customers List
Table 114. Recombinant Plasma Protein Therapeutics Market Trends
Table 115. Recombinant Plasma Protein Therapeutics Market Drivers
Table 116. Recombinant Plasma Protein Therapeutics Market Challenges
Table 117. Recombinant Plasma Protein Therapeutics Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Plasma Protein Therapeutics
Figure 2. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Plasma Protein Therapeutics Market Share by Type in 2023 & 2030
Figure 4. Recombinant Coagulation Factors Product Picture
Figure 5. Human C1 Esterase Inhibitor Product Picture
Figure 6. Global Recombinant Plasma Protein Therapeutics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Plasma Protein Therapeutics Market Share by Application in 2023 & 2030
Figure 8. Hemophilia A
Figure 9. Hemophilia B
Figure 10. Von Willebrand Disease
Figure 11. Global Recombinant Plasma Protein Therapeutics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Plasma Protein Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Plasma Protein Therapeutics Sales (2019-2030) & (K Units)
Figure 14. Global Recombinant Plasma Protein Therapeutics Average Price (USD/Unit) & (2019-2030)
Figure 15. Recombinant Plasma Protein Therapeutics Report Years Considered
Figure 16. Recombinant Plasma Protein Therapeutics Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Plasma Protein Therapeutics Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Recombinant Plasma Protein Therapeutics Players: Market Share by Revenue in 2023
Figure 19. Recombinant Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Plasma Protein Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Plasma Protein Therapeutics Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Plasma Protein Therapeutics Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 45. Latin America Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Recombinant Plasma Protein Therapeutics Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Recombinant Plasma Protein Therapeutics Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Recombinant Plasma Protein Therapeutics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Recombinant Plasma Protein Therapeutics by Type (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Plasma Protein Therapeutics by Type (2019-2030)
Figure 56. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Recombinant Plasma Protein Therapeutics by Application (2019-2030)
Figure 58. Global Revenue Market Share of Recombinant Plasma Protein Therapeutics by Application (2019-2030)
Figure 59. Global Recombinant Plasma Protein Therapeutics Price (USD/Unit) by Application (2019-2030)
Figure 60. Recombinant Plasma Protein Therapeutics Value Chain
Figure 61. Recombinant Plasma Protein Therapeutics Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed